NISHIYAMA Hiroyuki
- Articles
- Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Ando Yuichi; Nishiyama Hiroyuki; Shimodaira Hideki; Ta...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1315-1332, 2023-10 - Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study
Koyama Juntaro; Yamashita Shinichi; Kakimoto Kenichi; ...
INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2023-07-31 - Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
Nishiyama Hiroyuki; Inoue Takamitsu; Koizumi Yuichi; K...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1298-1314, 2023-10 - Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study
Nishiyama Hiroyuki; Tsuzuki Toyonori; Ohyama Chikara; ...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(10)/pp.1398-1410, 2023-10 - Safety and effectiveness of pembrolizumab monotherapy in Japanese patients with unresectable urothelial carcinoma: a nation-wide post-marketing surveillance
Nishiyama Hiroyuki; Tanaka Yu; Hamada Masahiro; Ozaki ...
BMC CANCER/23(1), 2023-06-20 - Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Hamada Kazuki; Nagumo Yoshiyuki; Kandori Shuya; Tanuma...
ONCOLOGY LETTERS/26(3), 2023-09 - Re: Predictive Biomarkers for Survival Benefit With Ramucirumab in Urothelial Cancer in the RANGE Trial Editorial Comment
van der Heijden M. S.; Powles T.; Petrylak D.; de Wit ...
JOURNAL OF UROLOGY/209(1)/pp.291-291, 2023-01 - Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors
Naito Yoichi; Mishima Saori; Akagi Kiwamu; Hayashi Na...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(7:SI)/pp.827-840, 2023-07 - Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors
Mishima Saori; Naito Yoichi; Akagi Kiwamu; Hayashi Na...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/28(8:SI)/pp.941-955, 2023-08 - Can cystoscopy artificial intelligence overcome differences between cystoscope products?
Ikeda A.; Nosato H.; Takaoka S.; Negoro H.; Sakanashi...
EUROPEAN UROLOGY/83(1)/pp.S845-S845, 2023-02 - A need for clear definitions and improved management for BCG-unresponsive tumors in Asia-Pacific
Lee L. S.; Kanesvaran R.; Kikuchi E.; Kitamura H.; Ku...
ANNALS OF ONCOLOGY/33(9)/pp.S1491-S1491, 2022-11 - Efficacy and safety of pembrolizumab (pembro) monotherapy in East Asian patients (pts) with urothelial carcinoma (UC) in KEYNOTE-045 or KEYNOTE-052
Lee J-L.; Keam B.; Kanesvaran R.; Yamamoto Y.; Su W-...
ANNALS OF ONCOLOGY/33(9)/pp.S1485-S1486, 2022-11 - Use of neoadjuvant chemotherapy for non-metastatic muscle-invasive bladder cancer in Asia-Pacific
Kanesvaran R.; Kikuchi E.; Kitamura H.; Ku J. H.; Lee...
ANNALS OF ONCOLOGY/33(9)/pp.S1491-S1492, 2022-11 - Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART): An open-label, single-arm, multicenter, phase II trial
Nagumo Y.; Kimura T.; Ishikawa H.; Sekino Y.; Maruo ...
ANNALS OF ONCOLOGY/33(7:7)/pp.S1332-S1333, 2022-09 - [Maturation and Development of the"All Japan E-Learning Cloud of the Training Program for Oncology Professionals]
Kim Jaejeong; Owada Yohei; Kojo Kosuke; Sanuki Masaru; Ta...
Gan to kagaku ryoho. Cancer & chemotherapy/49(5)/pp.520-524, 2022-05-01 - [Management of Chronic Kidney Disease in Cancer Survivors]
Kondoh Chihiro; Ishikura Kenji; Ichioka Satoko; Omae ...
Gan to kagaku ryoho. Cancer & chemotherapy/49(11)/pp.1200-1204, 2022-11-01 - [Management of Chronic Kidney Disease in Cancer Survivors]
Kondoh Chihiro; Ishikura Kenji; Ichioka Satoko; Omae ...
Gan to kagaku ryoho. Cancer & chemotherapy/49(11)/pp.1200-1204, 2022-11-01 - [Two Cases of Femoral Nerve Palsy after Pelvic Surgery]
Kinase Satoka; Hoshi Akio; Iimura Tsubasa; Sakurai Hi...
Hinyokika kiyo. Acta urologica Japonica/69(1)/pp.25-28, 2023-01-01 - Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial
Tomita Yoshihiko; Kobayashi Ko; Kimura Go; Oya Mototsugu...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/53(1)/pp.16-25, 2023-01-06 - C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guerin therapy: A Japan Urological Oncology Group study analysis
Nishikawa Ryoma; Miyake Makito; Morizane Shuichi; Shim...
INTERNATIONAL JOURNAL OF UROLOGY/30(3)/pp.299-307, 2023-03-01 - A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in Japan
Matsuoka Ayumu; Shimazu Taichi; Takahashi Masahiro; Na...
JOURNAL OF GERIATRIC ONCOLOGY/14(1), 2023-01-01 - FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression
Sternberg Cora N; Petrylak Daniel P; Bellmunt Joaquim; ...
JOURNAL OF CLINICAL ONCOLOGY/41(3)/pp.629-639, 2023-01-20 - FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression
Sternberg Cora N; Petrylak Daniel P; Bellmunt Joaquim; ...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology/41(3)/pp.629-639, 2023-01-20 - Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study
Kato Renpei; Naito Sei; Numakura Kazuyuki; Hatakeyama ...
International journal of clinical oncology/28(5)/pp.726-727, 2023-05-01 - Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG
Numakura Kazuyuki; Miyake Makito; Kobayashi Mizuki; Mu...
Cancers/15(7), 2023-03-28 - more...
- Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022